Doctor profile · Federal record

Dr. Reynaldo Mulingtapang, M.D.

Interventional Cardiology Physician · Cardiovascular Disease Physician · Tampa, FL

  • NPI 1033114509
  • 21 yrs on file
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
4210 W Linebaugh Ave
Tampa, FL 336245241
(813) 884-0923
fax (813) 377-1006
Mailing address
38135 Market Sq
Zephyrhills, FL 335427505

Credentials & registration

NPPES · NUCC
NPI registered
June 2005 — 21 yrs on file
Profile last updated
September 1, 2021
Specialty taxonomy
207RI0011X — NUCC code
State licenses (2)
Florida #ME58722 · Florida #ME0058722
Medicaid
FL #255447000

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1033114509. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,603
Distinct HCPCS
10
Medicare allowed
$487,040
HCPCS Description Services Patients Avg allowed
J2785 Injection, regadenoson, 0.1 mg 528 131 $53
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 384 192 $437
99214 Established patient office or other outpatient visit, 30-39 minutes 291 199 $124
93298 Evaluation of cardiac rhythm monitor system, remote up to 30 days 268 44 $26
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec 267 43 $35
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function 230 211 $186
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect 192 192 $412
93015 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician 138 138 $59
99205 New patient office or other outpatient visit, 60-74 minutes 60 60 $217
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report 52 47 $14

In context: peer comparison

Among 8 peers in Tampa Interventional Cardiology Physician, average services per provider: 88. This provider delivers 30× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$807
Transactions
29
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
Medtronic, INC. 2 $202.43
E.R. Squibb & Sons, L.L.C. 11 $137.81
Boston Scientific Corporation 4 $126.22
Biotronik INC. 2 $116.28
Boehringer Ingelheim Pharmaceuticals, INC. 2 $59.74
Janssen Pharmaceuticals, INC 2 $30.48
Kiniksa Pharmaceuticals International, Plc 1 $24.87
iRhythm Technologies, INC. 1 $24.39
Philips North America LLC 1 $22.80
Novo Nordisk INC 1 $21.72
Azurity Pharmaceuticals, INC. 1 $21.28
Amgen INC. 1 $18.84

By nature of payment

Food and Beverage
$807

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,905
Patients
729
Total drug cost
$159,148
Drug Type Claims Patients Total cost
Rosuvastatin Calcium Generic 215 85 $3,352
Carvedilol Generic 201 79 $2,290
Amlodipine Besylate Generic 188 69 $1,640
Losartan Potassium Generic 184 72 $3,711
Metoprolol Succinate Generic 148 56 $4,196
Clopidogrel (Clopidogrel Bisulfate) Brand 136 49 $2,023
Atorvastatin Calcium Generic 126 49 $2,144
Eliquis (Apixaban) Brand 126 31 $131,235
Lisinopril Generic 115 52 $935
Isosorbide Mononitrate ER (Isosorbide Mononitrate) Brand 114 35 $2,336

Frequently asked questions

Auto-generated from federal data
What is Dr. Reynaldo Mulingtapang's medical specialty?
Dr. Reynaldo Mulingtapang practices Interventional Cardiology Physician in Tampa, FL.
Where does Dr. Reynaldo Mulingtapang practice?
Dr. Reynaldo Mulingtapang practices at 4210 W Linebaugh Ave, Tampa, FL 336245241. Office phone: 8138840923.
What is Dr. Reynaldo Mulingtapang's NPI?
Dr. Reynaldo Mulingtapang's National Provider Identifier (NPI) is 1033114509, issued by NPPES.
What procedures does Dr. Reynaldo Mulingtapang commonly perform?
Top Medicare-reported procedures in 2023: Injection, regadenoson, 0.1 mg (HCPCS J2785); Technetium tc-99m tetrofosmin, diagnostic, per study dose (HCPCS A9502); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.